Abstract
Human molecular cytogenetics integrates the knowledge on chromosome and genome organization at the molecularand cellular levels in health and disease. Molecular cytogenetic diagnosis is an integral part of current genomicmedicine and is the standard of care in medical genetics and cytogenetics, reproductive medicine, pediatrics, neuropsychiatryand oncology. Regardless numerous advances in this field made throughout the last two decades, researchers andpractitioners who apply molecular cytogenetic techniques may encounter several problems that are extremely difficult tosolve. One of them is undoubtedly the occurrence of somatic genome and chromosome variations, leading to genomic andchromosomal mosaicism, which are related but not limited to technological and evaluative limitations as well as multiplicityof interpretations. More dramatically, current biomedical literature almost lacks descriptions, guidelines or solutions ofthese problems. The present article overviews all these problems and gathers those exclusive data acquired from studies ofgenome and chromosome instability that is relevant to identification and interpretations of this fairly common cause ofsomatic genomic variations and chromosomal mosaicism. Although the way to define pathogenic value of all the intercellularvariations of the human genome is far from being completely understood, it is possible to propose recommendationson molecular cytogenetic diagnosis and management of somatic genome variations in clinical population.
Keywords: Molecular cytogenetics, somatic genome variations, molecular diagnosis, chromosome instability, genomic instability, mosaicism
Current Genomics
Title: Molecular Cytogenetic Diagnosis and Somatic Genome Variations
Volume: 11 Issue: 6
Author(s): S. G. Vorsanova, Y. B. Yurov, I. V. Soloviev and I. Y. Iourov
Affiliation:
Keywords: Molecular cytogenetics, somatic genome variations, molecular diagnosis, chromosome instability, genomic instability, mosaicism
Abstract: Human molecular cytogenetics integrates the knowledge on chromosome and genome organization at the molecularand cellular levels in health and disease. Molecular cytogenetic diagnosis is an integral part of current genomicmedicine and is the standard of care in medical genetics and cytogenetics, reproductive medicine, pediatrics, neuropsychiatryand oncology. Regardless numerous advances in this field made throughout the last two decades, researchers andpractitioners who apply molecular cytogenetic techniques may encounter several problems that are extremely difficult tosolve. One of them is undoubtedly the occurrence of somatic genome and chromosome variations, leading to genomic andchromosomal mosaicism, which are related but not limited to technological and evaluative limitations as well as multiplicityof interpretations. More dramatically, current biomedical literature almost lacks descriptions, guidelines or solutions ofthese problems. The present article overviews all these problems and gathers those exclusive data acquired from studies ofgenome and chromosome instability that is relevant to identification and interpretations of this fairly common cause ofsomatic genomic variations and chromosomal mosaicism. Although the way to define pathogenic value of all the intercellularvariations of the human genome is far from being completely understood, it is possible to propose recommendationson molecular cytogenetic diagnosis and management of somatic genome variations in clinical population.
Export Options
About this article
Cite this article as:
Vorsanova G. S., Yurov B. Y., Soloviev V. I. and Iourov Y. I., Molecular Cytogenetic Diagnosis and Somatic Genome Variations, Current Genomics 2010; 11 (6) . https://dx.doi.org/10.2174/138920210793176010
DOI https://dx.doi.org/10.2174/138920210793176010 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Mitochondrial Oxidative Stress Through Lipoic Acid Synthase: A Novel Strategy to Manage Diabetic Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Enhanced Regularized Ensemble Encoderdecoder Network for Accurate Brain Tumor Segmentation
Current Medical Imaging Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting
Infectious Disorders - Drug Targets Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods
Current Medicinal Chemistry <i>In vitro</i> and <i>In vivo</i> Toxicity Assessment of Metallic Nanoparticulate Systems for Skin Targeting
Current Nanotoxicity and Prevention (Discontinued) Alternative Routes of Administration of the Neuroprotective Pituitary Adenylate Cyclase Activating Polypeptide
Current Pharmaceutical Design Dose-Intensive Chemotherapy with Stem Cell Support as a Treatment Strategy for Bone and Soft-Tissue Sarcomas
Current Stem Cell Research & Therapy Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins
Current Computer-Aided Drug Design Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer’s Disease and Correlation with Cerebral Hypoperfusion Pattern
Current Alzheimer Research Investigation of Antioxidant Activity and Analysis of Phenolic Compounds of some Asteraceae Plants by HPLC: A Comparison Between Methanol and Ethanol Extracts
Current Nutraceuticals Effects of Ascorbic Acid on Tax, NF-κB and MMP-9 in Human T-cell Lymphotropic Virus Type 1 Positive Malignant T-Lymphocytes
Anti-Cancer Agents in Medicinal Chemistry Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders
Current Protein & Peptide Science Analysis of Four Types of Leukemia Using Gene Ontology Term and Kyoto Encyclopedia of Genes and Genomes Pathway Enrichment Scores
Combinatorial Chemistry & High Throughput Screening Dopamine: Agonists and Neurodegenerative Disorders
Current Drug Targets Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design Anti-pathogenic Strategies for Fighting Pseudomonas aeruginosa Infections- probiotic Soluble Compounds as Inhibitors of Quorum Sensing Genes Expression
Current Organic Chemistry Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome
Current Pharmaceutical Design Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis
Current Pharmaceutical Biotechnology Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
Current Pharmaceutical Design